DERM
Journey Medical Corporation
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$7.86
−0.51%Forward multiples
Based on analyst estimates
- P/E forward
- 39.80x
- P/E 2026E
- —
- P/E 2027E
- 11.63x
- P/E 2028E
- 4.76x
- P/S forward
- 2.20x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.91x
- Price / sales
- 3.25x
- Price / cash flow
- -29.61x
Enterprise value
- Enterprise value
- $221.7M
- EV / sales
- 3.25x
- EV / EBITDA
- 119.93x
- EV / EBIT
- -73.72x
- Market cap
- $221.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026